IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro

Eur J Immunol. 2010 Oct;40(10):2686-91. doi: 10.1002/eji.201040673.


IL-10-producing regulatory B cells have been identified in mice and shown to downregulate inflammation, making them potentially important for maintenance of tolerance. In this study, we isolated B cells from human blood and spleen, and showed that after a short period of ex vivo stimulation a number of these cells produced IL-10. The IL-10-producing B cells did not fall within a single clearly defined subpopulation, but were enriched in both the memory (CD27(+)) and the transitional (CD38(high)) B-cell compartments. Combined CpG-B+anti-Ig stimulation was the most potent IL-10 stimulus tested. B cells stimulated in this way inhibited CD4(+)CD25(-) T-cell proliferation in vitro by a partially IL-10-dependent mechanism. These findings imply that manipulating IL-10 production by human B cells could be a useful therapeutic strategy for modulating immune responses in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoimmunity / immunology
  • B-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / immunology*
  • Cell Proliferation
  • Flow Cytometry
  • Humans
  • Immune Tolerance / immunology
  • Interleukin-10 / biosynthesis*
  • Interleukin-10 / immunology
  • Lymphocyte Activation / immunology
  • Receptors, Antigen, B-Cell / immunology
  • Toll-Like Receptor 9 / immunology


  • Receptors, Antigen, B-Cell
  • TLR9 protein, human
  • Toll-Like Receptor 9
  • Interleukin-10